Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.
To determine the relative contributions of triglycerides (TGs) and high-density lipoprotein (HDL) cholesterol in the residual risk of coronary heart disease (CHD) after the reduction of low-density lipoprotein (LDL) cholesterol to guideline-recommended levels, we conducted a hospital-based, case-control study with optimal matching in the strata of LDL cholesterol, gender, ethnicity, and age. The 170 cases and 175 controls were patients at Brigham and Women's Hospital (Boston, Massachusetts) from 2005 to 2008 who had an LDL cholesterol level <130 mg/dl. The cases had incident CHD, and the controls had diagnoses unrelated to CHD. The 170 cases and 175 controls had a mean LDL cholesterol level of 73 and 87 mg/dl, respectively. The association between TG and HDL cholesterol levels and CHD risk was assessed using conditional and unconditional logistic regression analysis. The models investigated accommodated the possibility of an interaction between lipid factors. The odds of CHD increased by approximately 20% per 23-mg/dl increase in TGs and decreased by approximately 40% per 7.5-mg/dl decrease in HDL cholesterol. High TGs and low HDL cholesterol interacted synergistically to increase the odds ratio to 10 for the combined greatest TG (> or =190 mg/dl) and lowest HDL cholesterol quintiles (<30 mg/dl). High TG levels were more strongly associated with CHD when the HDL cholesterol was low than average or high; and low HDL cholesterol levels were more strongly associated with CHD when the TGs were high. TGs and HDL cholesterol were associated with CHD in patients with a LDL cholesterol level of < or =70 mg/dl, with a risk similar to, or greater than, those in the total group. In conclusion, high TG and low HDL cholesterol levels contribute strongly and synergistically to CHD when LDL cholesterol is well controlled. Thus, high TGs might have greater importance in patients with optimal rather than greater LDL cholesterol concentrations.
Carey
Vincent J
VJ
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. stvjc@channing.harvard.edu
Bishop
Louise
L
Laranjo
Nancy
N
Harshfield
Benjamin J
BJ
Kwiat
Carolyn
C
Sacks
Frank M
FM
D000368:Aged; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012044:Regression Analysis; D012306:Risk; D014280:Triglycerides / Q000097:blood*
D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides
Circulation. 2007 Jan 30;115(4):450-8
17190864
Circulation. 2000 Oct 17;102(16):1886-92
11034934
Circulation. 2004 Jul 13;110(2):227-39
15249516
J Lipid Res. 2007 May;48(5):1190-203
17314277
Lancet. 2005 Oct 8;366(9493):1267-78
16214597
J Clin Invest. 2006 Dec;116(12):3090-100
17143322
J Am Coll Cardiol. 2008 Feb 19;51(7):724-30
18279736
Circulation. 2000 Oct 17;102(16):1893-900
11034935
Biometrics. 1982 Sep;38(3):661-72
7171694
N Engl J Med. 2007 Sep 27;357(13):1301-10
17898099
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):853-8
12637336
BMC Med Inform Decis Mak. 2006 Jul 26;6:30
16872495
Circulation. 2002 Mar 26;105(12):1424-8
11914249
Circulation. 2006 Aug 15;114(7):681-7
16894036
J Am Coll Cardiol. 2008 Apr 15;51(15):1440-5
18402897
Annu Rev Nutr. 2006;26:105-29
16704350